MAP3K3 and non-small cell lung carcinoma: In non-small-cell lung cancer, XIST has been reported to regulate the cell proliferation and apoptosis by modulating the MAP3K3 pathway, and the MAPK pathway was associated with the PD pathogenesis [24].